Christina Bahrs
Overview
Explore the profile of Christina Bahrs including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
21
Citations
119
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Bahrs C, Schonherr C, Panning M, Rose N, Dahne T, Hagel S, et al.
Infection
. 2024 Jul;
53(1):449-455.
PMID: 39033207
Purpose: This study assessed the frequency, clinical significance, and risk factors for Herpes simplex virus (HSV) reactivation in immunocompetent patients with community-acquired pneumonia (CAP). Methods: The study included adult CAP-patients...
2.
Wagenlehner F, Kresken M, Wohlfarth E, Bahrs C, Grabein B, Strohmaier W, et al.
Urologie
. 2023 Aug;
62(11):1186-1192.
PMID: 37650911
Background: According to German AWMF S3 guideline nitroxoline is recommended as one of the first-choice antibiotics for treatment of acute uncomplicated cystitis (UC) in women. Under real-world conditions the clinical...
3.
Tobudic S, Bahrs C, Schneider L, Paulussen E, Bartonickova L, Hagel S, et al.
Infection
. 2023 Jul;
51(6):1749-1758.
PMID: 37462895
Purpose: This study aimed to compare treatment outcomes for bloodstream infections (BSI) caused by a piperacillin/tazobactam (PIP/TAZ)-susceptible E. coli among three patient groups: BSI caused by ampicillin/sulbactam (AMP/SLB)-resistant isolates treated...
4.
Werner G, Abu Sin M, Bahrs C, Brogden S, Fessler A, Hagel S, et al.
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz
. 2023 May;
66(6):628-643.
PMID: 37184673
One Health refers to a concept that links human, animal, and environmental health. In Germany, there is extensive data on antibiotic resistance (AMR) and multidrug-resistant (micro)organisms (MDRO) in human and...
5.
Rademacher J, Bahrs C
MMW Fortschr Med
. 2023 May;
165(9):40-42.
PMID: 37155062
No abstract available.
6.
Bahrs C, Weis S, Kesselmeier M, Ankert J, Hagel S, Beier S, et al.
Infection
. 2023 Feb;
51(4):1051-1059.
PMID: 36788173
Purpose: The Co-HCW study is a prospective, longitudinal, single-center observational study that aims to assess the SARS-CoV-2 seroprevalence and infection status in staff members of Jena University Hospital (JUH) in...
7.
Pletz M, Jensen A, Bahrs C, Davenport C, Rupp J, Witzenrath M, et al.
Respir Res
. 2022 Sep;
23(1):239.
PMID: 36088316
Introduction: Despite improvements in medical science and public health, mortality of community-acquired pneumonia (CAP) has barely changed throughout the last 15 years. The current SARS-CoV-2 pandemic has once again highlighted...
8.
Bahrs C, Rieg S, Hennigs A, Hitzenbichler F, Brehm T, Rose N, et al.
Clin Microbiol Infect
. 2022 Sep;
29(2):200-207.
PMID: 36087919
Objectives: The optimal treatment duration for vancomycin-resistant enterococcal (VRE) bacteraemia is still a matter of debate. The aim of the present study was to compare short-course (≤9 days) and long-course...
9.
Weis S, Hagel S, Palm J, Scherag A, Kolanos S, Bahrs C, et al.
JAMA Netw Open
. 2022 Jun;
5(6):e2218515.
PMID: 35749114
Importance: Staphylococcus aureus bacteremia (SAB) is a common and potentially severe infectious disease (ID). Retrospective studies and derived meta-analyses suggest that bedside infectious disease consultation (IDC) for SAB is associated...
10.
Bahrs C, Harrison N
Vaccines (Basel)
. 2022 Jun;
10(6).
PMID: 35746489
During the last few years, we have experienced a shift in how we evaluate the effectiveness of vaccines [...].